2023 Q2 Form 10-Q Financial Statement

#000106299323010672 Filed on May 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.579M $2.737M $2.225M
YoY Change -22.04% -63.57% -34.41%
% of Gross Profit
Research & Development $7.599M $6.838M $5.300M
YoY Change 101.49% 461.76% 157.46%
% of Gross Profit
Depreciation & Amortization $63.25K $60.74K $57.77K
YoY Change 31.16% 98.56% 27.95%
% of Gross Profit
Operating Expenses $10.18M $9.575M $7.525M
YoY Change 43.76% 9.66% 38.06%
Operating Profit -$10.18M -$9.575M
YoY Change 43.76% 25.36%
Interest Expense $41.05K $34.64K $62.77K
YoY Change 74.68% 543.14%
% of Operating Profit
Other Income/Expense, Net $41.05K $34.64K
YoY Change -22.15% -75.28%
Pretax Income -$10.14M -$9.541M -$7.462M
YoY Change 44.25% 9.51% 37.15%
Income Tax -$314.6K -$274.5K -$565.3K
% Of Pretax Income
Net Earnings -$9.823M -$9.266M -$6.897M
YoY Change 69.1% -192.29% 26.76%
Net Earnings / Revenue
Basic Earnings Per Share -$0.13 -$0.13
Diluted Earnings Per Share -$0.13 -$0.13 -$0.10
COMMON SHARES
Basic Shares Outstanding 75.31M shares 73.74M shares 73.18M shares
Diluted Shares Outstanding 75.94M shares 73.74M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.44M $20.27M $23.91M
YoY Change -55.94% -51.03% -48.73%
Cash & Equivalents $15.44M $20.27M $23.91M
Short-Term Investments
Other Short-Term Assets $696.5K $852.7K $618.9K
YoY Change -28.22% 126.36% 256.51%
Inventory
Prepaid Expenses
Receivables $124.7K $115.9K $107.4K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $16.26M $21.24M $24.64M
YoY Change -55.67% -49.27% -47.37%
LONG-TERM ASSETS
Property, Plant & Equipment $1.621M $1.251M $1.267M
YoY Change 26.26% 1.76% -94.15%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $350.6K $348.4K $380.7K
YoY Change 776.59% 1641.97%
Total Long-Term Assets $80.81M $80.36M $80.38M
YoY Change 3.17% 2.74% 271.49%
TOTAL ASSETS
Total Short-Term Assets $16.26M $21.24M $24.64M
Total Long-Term Assets $80.81M $80.36M $80.38M
Total Assets $97.07M $101.6M $105.0M
YoY Change -15.59% -15.39% 53.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.621M $1.931M $1.752M
YoY Change -25.57% 182.81%
Accrued Expenses $935.4K $534.2K $635.0K
YoY Change 174.14% 14.16%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.578M $2.482M $2.515M
YoY Change 1.17% -2.16% 305.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.578M $2.482M $2.515M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.321M $3.540M $3.847M
YoY Change -34.14% -43.36% 520.88%
SHAREHOLDERS EQUITY
Retained Earnings -$25.30M -$15.48M -$6.216M
YoY Change -448.68% -218.49%
Common Stock $76.86K $75.29K $73.34K
YoY Change 6.75% 6.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $93.75M $98.06M $101.2M
YoY Change
Total Liabilities & Shareholders Equity $97.07M $101.6M $105.0M
YoY Change -15.59% -15.39% 53.43%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income -$9.823M -$9.266M -$6.897M
YoY Change 69.1% -192.29% 26.76%
Depreciation, Depletion And Amortization $63.25K $60.74K $57.77K
YoY Change 31.16% 98.56% 27.95%
Cash From Operating Activities -$8.575M -$8.462M -$6.080M
YoY Change 38.07% 101.58% 155.83%
INVESTING ACTIVITIES
Capital Expenditures $515.4K $44.63K $279.5K
YoY Change 401.17% -101.87% -108.72%
Acquisitions
YoY Change
Other Investing Activities $7.390K -$7.390K
YoY Change -63.05%
Cash From Investing Activities -$508.0K -$72.02K -$279.5K
YoY Change 216.08% -97.01% -91.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 4.249M $4.895M 2.203M
YoY Change 35310.5% 1436.64% -153104.17%
NET CHANGE
Cash From Operating Activities -8.575M -$8.462M -6.080M
Cash From Investing Activities -508.0K -$72.02K -279.5K
Cash From Financing Activities 4.249M $4.895M 2.203M
Net Change In Cash -4.834M -$3.639M -4.157M
YoY Change -23.99% -42.14% -25.54%
FREE CASH FLOW
Cash From Operating Activities -$8.575M -$8.462M -$6.080M
Capital Expenditures $515.4K $44.63K $279.5K
Free Cash Flow -$9.090M -$8.506M -$6.360M
YoY Change 43.99% 370.37% -868.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73744247 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
35641666 shares
CY2022Q1 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3239342 usd
CY2022Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
0 usd
CY2023Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
7389 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.89
CY2023Q1 dc Proceeds From Sale Of Common Stock On At The Market Program
ProceedsFromSaleOfCommonStockOnAtTheMarketProgram
5000020 usd
CY2022Q1 dc Proceeds From Sale Of Common Stock On At The Market Program
ProceedsFromSaleOfCommonStockOnAtTheMarketProgram
0 usd
CY2023Q1 dc Withholding Of Employee Tax Payments On Performance Stock Units
WithholdingOfEmployeeTaxPaymentsOnPerformanceStockUnits
38000 usd
CY2022Q1 dc Withholding Of Employee Tax Payments On Performance Stock Units
WithholdingOfEmployeeTaxPaymentsOnPerformanceStockUnits
0 usd
CY2022Q1 dc Deferred Atm Offering Costs Offset Against Additional Paid In Capital
DeferredAtmOfferingCostsOffsetAgainstAdditionalPaidInCapital
0 usd
CY2023Q1 dc Withholding Of Employee Tax Payment On Psu
WithholdingOfEmployeeTaxPaymentOnPsu
38000 usd
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y8M4D
CY2023Q1 us-gaap Fiscal Period
FiscalPeriod
<div> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;"><span style="text-decoration: underline;">Change in Fiscal Year</span></span></span></p> <p style="text-align: justify;"><span style="font-size: 10pt;"><span style="font-family: Times New Roman,Times,serif;">In August 2022, the Board of Directors of the Company, pursuant to the bylaws and based upon the recommendation of its Audit Committee, approved a change in the Company's fiscal year end from March 31 to December 31. The Company's fiscal year now begins on January 1 and ends on December 31 of each year, starting on January 1, 2023.</span></span></p> </div>
CY2022Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2023Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
1 pure
CY2022Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
15000 usd
CY2023Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
15000 usd
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
37500 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
333588 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.81
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
647649 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3999572 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2022Q1 dc Options Issued Upon Acquisition Of Non Controlling Interest
OptionsIssuedUponAcquisitionOfNonControllingInterest
3349375 shares
CY2022Q1 dc Options Issued Upon Acquisition Of Non Controlling Interest Of Weighted Average Exercise Price
OptionsIssuedUponAcquisitionOfNonControllingInterestOfWeightedAverageExercisePrice
4.06
CY2022Q1 dc Options Issued Upon Acquisition Of Non Controlling Interest On Remaining Contractual Life
OptionsIssuedUponAcquisitionOfNonControllingInterestOnRemainingContractualLife
P4Y1M13D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3349375 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.06
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y1M13D
CY2023Q1 dc Share Based Payment Arrangement Non Vested Award Option Restricted Stock Units
ShareBasedPaymentArrangementNonVestedAwardOptionRestrictedStockUnits
1530323 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P1Y4M28D

Files In Submission

Name View Source Status
dc-20230331_cal.xml Edgar Link unprocessable
dc-20230331_pre.xml Edgar Link unprocessable
dc-20230331_lab.xml Edgar Link unprocessable
dc-20230331_def.xml Edgar Link unprocessable
0001062993-23-010672-index-headers.html Edgar Link pending
0001062993-23-010672-index.html Edgar Link pending
0001062993-23-010672.txt Edgar Link pending
0001062993-23-010672-xbrl.zip Edgar Link pending
dc-20230331.xsd Edgar Link pending
exhibit31-1.htm Edgar Link pending
exhibit31-2.htm Edgar Link pending
exhibit32-1.htm Edgar Link pending
exhibit32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
form10qxz001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10q_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending